Arkolith/Insider Trading/CLTX/Form 4

Cohen Mark S

DirectorCelsus Therapeutics Plc. (CLTX) · full profile →Form 4 · filed Jan 12, 2015
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 8, 2015Option exercise(X)51K$0.02$1K51K
Jan 8, 2015Option exercise(X)152K$0.02$3K152K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 8, 2015Option exercise(X)51K—$00
Jan 8, 2015Option exercise(X)152K—$00

Transaction Codes

X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001144204-15-001832) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Celsus Therapeutics Plc.

Build

Ask your agent about CLTX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001144204-15-001832"
Ask your agent
Use Arkolith to summarize insider buying and selling at Celsus Therapeutics Plc.
over the last 90 days and cite the filings.